首页 > 最新文献

Drug Invention Today最新文献

英文 中文
Synthesis of novel N-(3-chloro-4-flurophenyl)-2-(5-((3-(4-hydroxy-2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl)-1-phenyl-1H-pyrazol-4-yl) methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetamides having anti-inflammatory activity 合成具有抗炎活性的新型N-(3-氯-4-氟苯基)-2-(5-(3-(4-羟基- 2,2 -二甲基- 2,3 -二氢苯并呋喃-5-基)-1-苯基- 1h -吡唑-4-基)亚甲基)-4-氧-2-硫氧噻唑烷-3-基)乙酰胺
Pub Date : 2013-12-01 DOI: 10.1016/j.dit.2013.07.004
K. Shyam Sunder , Jayapal Maleraju

Eight derivatives of N-(3-chloro-4-fluorophenyl)-2-(5-((3-(4-hydroxy-2, 2-dimethyl l-2,3-dihydrobenzofuran-5-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetamide were synthesized by reacting pyrazole having substitutions at 1 and 3 positions (phenyl and benzofuran) with various substituted N-(3-chloro-4-fluorophenyl)-2-(4-oxo-2-thioxothiazolidin-3-yl)acetamides.The series of reactions are depicted in following scheme. The chemical structures of these compounds were confirmed by means of 1H NMR, IR and Mass spectra. The compounds were assayed for anti-inflammatory activity.

Among the compounds 10a, 10b and 10d showed significant anti-inflammatory activity, 10c showed moderate anti-inflammatory activity.

通过1位和3位取代的吡唑(苯基和苯并呋喃)与不同取代的N-(3-氯-4-氟苯基)-2-(4-(3-(4-羟基- 2,2 -二甲基-2,3-二氢苯并呋喃-5-基)-1-苯基- 1h -吡唑-4-基)乙酰胺反应,合成了8个N-(3-氯-4-氟苯基)-2-(4-氧-2-硫氧噻唑-3-基)乙酰胺衍生物。这一系列反应如下图所示。这些化合物的化学结构通过1H NMR、IR和质谱进行了确证。测定化合物的抗炎活性。其中化合物10a、10b和10d具有显著的抗炎活性,10c具有中等的抗炎活性。
{"title":"Synthesis of novel N-(3-chloro-4-flurophenyl)-2-(5-((3-(4-hydroxy-2, 2-dimethyl-2, 3-dihydrobenzofuran-5-yl)-1-phenyl-1H-pyrazol-4-yl) methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetamides having anti-inflammatory activity","authors":"K. Shyam Sunder ,&nbsp;Jayapal Maleraju","doi":"10.1016/j.dit.2013.07.004","DOIUrl":"10.1016/j.dit.2013.07.004","url":null,"abstract":"<div><p>Eight derivatives of N-(3-chloro-4-fluorophenyl)-2-(5-((3-(4-hydroxy-2, 2-dimethyl l-2,3-dihydrobenzofuran-5-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl) acetamide were synthesized by reacting pyrazole having substitutions at 1 and 3 positions (phenyl and benzofuran) with various substituted N-(3-chloro-4-fluorophenyl)-2-(4-oxo-2-thioxothiazolidin-3-yl)acetamides.The series of reactions are depicted in following scheme. The chemical structures of these compounds were confirmed by means of <sup>1</sup>H NMR, IR and Mass spectra. The compounds were assayed for anti-inflammatory activity.</p><p>Among the compounds <strong>10a</strong>, <strong>10b</strong> and <strong>10d</strong> showed significant anti-inflammatory activity, <strong>10c</strong> showed moderate anti-inflammatory activity.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 4","pages":"Pages 288-295"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.07.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89255815","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Comparative antioxidant efficacy of Citrus limonum pulp and peel – An in vitro study 柑桔柠檬果肉和果皮抗氧化效果的体外比较研究
Pub Date : 2013-12-01 DOI: 10.1016/j.dit.2013.07.003
Blessy Baby Mathew , Danie Shajie , Neha Wadhwa , N.B. Krishna Murthy , T.P. Krishna Murthy , M. Rashmi

Background

In the present study, the lemon pulp and peel along-with their secondary metabolites were studied and compared for its antioxidant activity.

Method

Various in vitro and ex vivo studies were done to estimate the polyphenols and flavonoids present in the lemon pulp and peel. The reducing power, free radical scavenging activity and lipid peroxide inhibition were investigated for the extracts.

Results

The lemon peel was found to have a slightly greater count of polyphenols and flavonoids, showing a difference of 0.2. The peel extracts also showed better reducing power and higher free radical scavenging activity. The peel extracts gave 82.3% of inhibition towards lipid peroxidation, when compared to the pulp extracts which showed an inhibition of 78.2%.

Conclusion

The antioxidant activity was found to be higher in the case of lemon peel when compared to the pulp.

本研究对柠檬果肉和柠檬皮及其次生代谢产物的抗氧化活性进行了研究和比较。方法采用体外和离体实验对柠檬果肉和柠檬皮中多酚类和黄酮类化合物的含量进行测定。考察了其还原力、自由基清除能力和脂质过氧化抑制能力。结果发现柠檬皮的多酚和类黄酮含量略高,差异为0.2。果皮提取物还具有较好的还原力和清除自由基的活性。果皮提取物对脂质过氧化的抑制率为82.3%,而果肉提取物的抑制率为78.2%。结论柠檬皮的抗氧化活性高于柠檬果肉。
{"title":"Comparative antioxidant efficacy of Citrus limonum pulp and peel – An in vitro study","authors":"Blessy Baby Mathew ,&nbsp;Danie Shajie ,&nbsp;Neha Wadhwa ,&nbsp;N.B. Krishna Murthy ,&nbsp;T.P. Krishna Murthy ,&nbsp;M. Rashmi","doi":"10.1016/j.dit.2013.07.003","DOIUrl":"10.1016/j.dit.2013.07.003","url":null,"abstract":"<div><h3>Background</h3><p>In the present study, the lemon pulp and peel along-with their secondary metabolites were studied and compared for its antioxidant activity.</p></div><div><h3>Method</h3><p>Various <em>in vitro</em> and <em>ex vivo</em> studies were done to estimate the polyphenols and flavonoids present in the lemon pulp and peel. The reducing power, free radical scavenging activity and lipid peroxide inhibition were investigated for the extracts.</p></div><div><h3>Results</h3><p>The lemon peel was found to have a slightly greater count of polyphenols and flavonoids, showing a difference of 0.2. The peel extracts also showed better reducing power and higher free radical scavenging activity. The peel extracts gave 82.3% of inhibition towards lipid peroxidation, when compared to the pulp extracts which showed an inhibition of 78.2%.</p></div><div><h3>Conclusion</h3><p>The antioxidant activity was found to be higher in the case of lemon peel when compared to the pulp.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 4","pages":"Pages 296-301"},"PeriodicalIF":0.0,"publicationDate":"2013-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88763681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Hepatoprotective effect of leaves of Morinda tinctoria Roxb. against paracetamol induced liver damage in rats 巴戟叶的保肝作用。抗扑热息痛引起的大鼠肝损伤
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.06.008
Mohanraj Subramanian , Sangameswaran Balakrishnan , Santhosh Kumar Chinnaiyan , Vinoth Kumar Sekar , Atul N. Chandu

Objective

To investigate the hepatoprotective activity of aqueous and methanol extracts of leaves of Morinda tinctoria Roxb. against paracetamol induced liver damage into rats.

Methods

The hepatoprotective activity aimed for plant extracts was investigated for paracetamol induced hepatotoxicity into rats. Sprague–Dawley rats of either sex were divided into 7 groups of 5 animals each and are given orally the following treatment for 10 days. The normal control was given 1% CMC 1 ml/kg b.w., p.o. Paracetamol at dose of 3 g/kg b.w., p.o. was given as toxic dose for inducing hepatotoxicity. Liv.52 (50 mg/animal, p.o) was given as reference standard. Two different doses of M. tinctoria extracts of both aqueous and methanol (100 mg/kg, p.o, 150 mg/kg, p.o) was tested for hepatoprotective activity. The treatment was given for 10 days and after 48 h of last treatment blood was collected from direct cardiac puncture and analysed for various serum parameter like serum glutamic pyruvic transaminase (SGPT), Serum glutamic oxaloacetic transaminase (SGOT), Total Bilirubin (TB), Direct Bilirubin and Total cholesterol (TC) in different groups.

Results

The phytochemical investigation of the both extracts showed the presence of alkaloids, flavonoids, glycosides, carbohydrates, saponin and tannin and phenols. The paracetamol intoxication lead to histological and biochemical deterioration. The treatment with both aqueous and methanolic leaves extracts of M. tinctoria reduced the level of SGOT, SGPT, TB, DB and TC and also reversed the hepatic damage towards normal which further supports the hepatoprotective activity of leaf extracts of M. tinctoria.

Conclusions

Both aqueous and methanol extracts of leaves of M.tinctoria have significant effect at higher dose of 150mg/kg.b.w.

目的研究桑三叶水提物和甲醇提物对肝脏的保护作用。对扑热息痛致大鼠肝损伤的研究。方法研究植物提取物对大鼠对乙酰氨基酚肝毒性的保护作用。将sd - dawley大鼠随机分为7组,每组5只,给药10 d。正常对照组给予1% CMC 1 ml/kg b.w, p.o.,对乙酰氨基酚3 g/kg b.w, p.o.作为肝毒性剂量。以Liv.52 (50 mg/只,p.o)作为参考标准。对两种不同剂量的桔梗水提物和甲醇提物(100 mg/kg, p.o, 150 mg/kg, p.o)的肝保护活性进行了测试。治疗10 d,末次治疗48 h后直接穿刺取血,分析各组血清谷丙转氨酶(SGPT)、谷草转氨酶(SGOT)、总胆红素(TB)、直接胆红素(direct Bilirubin)、总胆固醇(TC)等各项血清参数。结果两种提取物均含有生物碱、黄酮类、苷类、碳水化合物、皂苷、单宁和酚类物质。扑热息痛中毒导致组织和生化恶化。水提液和甲醇提液均降低了SGOT、SGPT、TB、DB和TC的水平,并使肝损伤恢复正常,进一步支持了三叶提取物的保肝活性。结论在150mg/kg.b.w的高剂量下,水提物和甲醇提物均具有显著的抗氧化作用。
{"title":"Hepatoprotective effect of leaves of Morinda tinctoria Roxb. against paracetamol induced liver damage in rats","authors":"Mohanraj Subramanian ,&nbsp;Sangameswaran Balakrishnan ,&nbsp;Santhosh Kumar Chinnaiyan ,&nbsp;Vinoth Kumar Sekar ,&nbsp;Atul N. Chandu","doi":"10.1016/j.dit.2013.06.008","DOIUrl":"10.1016/j.dit.2013.06.008","url":null,"abstract":"<div><h3>Objective</h3><p>To investigate the hepatoprotective activity of aqueous and methanol extracts of leaves of <em>Morinda tinctoria</em> Roxb. against paracetamol induced liver damage into rats.</p></div><div><h3>Methods</h3><p>The hepatoprotective activity aimed for plant extracts was investigated for paracetamol induced hepatotoxicity into rats. Sprague–Dawley rats of either sex were divided into 7 groups of 5 animals each and are given orally the following treatment for 10 days. The normal control was given 1% CMC 1 ml/kg b.w., p.o. Paracetamol at dose of 3 g/kg b.w., p.o. was given as toxic dose for inducing hepatotoxicity. Liv.52 (50 mg/animal, p.o) was given as reference standard. Two different doses of <em>M. tinctoria</em> extracts of both aqueous and methanol (100 mg/kg, p.o, 150 mg/kg, p.o) was tested for hepatoprotective activity. The treatment was given for 10 days and after 48 h of last treatment blood was collected from direct cardiac puncture and analysed for various serum parameter like serum glutamic pyruvic transaminase (SGPT), Serum glutamic oxaloacetic transaminase (SGOT), Total Bilirubin (TB), Direct Bilirubin and Total cholesterol (TC) in different groups.</p></div><div><h3>Results</h3><p>The phytochemical investigation of the both extracts showed the presence of alkaloids, flavonoids, glycosides, carbohydrates, saponin and tannin and phenols. The paracetamol intoxication lead to histological and biochemical deterioration. The treatment with both aqueous and methanolic leaves extracts of <em>M. tinctoria</em> reduced the level of SGOT, SGPT, TB, DB and TC and also reversed the hepatic damage towards normal which further supports the hepatoprotective activity of leaf extracts of <em>M. tinctoria</em>.</p></div><div><h3>Conclusions</h3><p>Both aqueous and methanol extracts of leaves of M.tinctoria have significant effect at higher dose of 150mg/kg.b.w.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 223-228"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.06.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85984676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Synthesis, characterization and in-vitro anti-inflammatory activity of some substituted 1,2,3,4 tetrahydropyrimidine derivatives 一些取代的1,2,3,4四氢嘧啶衍生物的合成、表征及体外抗炎活性
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.04.004
Anita S. Gondkar, Vinayak K. Deshmukh, Sanjay R. Chaudhari

Background & aim

Pyrimidines represent a broad class of compounds, which have received considerable attention due to their wide range of biological activities such as, anti-inflammatory, COX inhibitor, anticancer, antiallergic and analgesic. On the basis of exhaustive literature review and PASS predictions, it has been found that substituted 1,2,3,4 tetrahydropyrimidine derivatives have good potential to exhibit in vitro anti-inflammatory activity.

Method

The toxicity and pharmacological activities of synthesized compounds were studied with the help of softwares. The non-toxic compounds, which are having Pa (Probable activity), value more than 0.3 & less than 0.5 were synthesized. A novel procedure for synthesis of substituted 1,2,3,4-tetrahydropyrimidine was reported by the reaction of urea (0.01 mmol) and bis(methylthio)methylenemalononitrile (0.01 mmol). Substituted 1, 2, 3, 4-tetrahydropyrimidine possess a replaceable active methylthio group at the 6th position, which was substituted with selected nucleophiles to get final compounds.

Result

All synthesized compounds were characterized by IR, 1H-NMR, MS and elemental analysis. All compounds were screened for in-vitro anti-inflammatory activity by inhibition of protein denaturation method using diclofenac as a standard drug. The results revealed that almost all the tested compounds showed potent in-vitro anti-inflammatory activity.

Conclusion

The obtained results for anti-inflammatory prove the necessity for further investigation to clarify the features underlying the anti-inflammatory potential of tested compounds. Substituted 1, 2, 3, 4-tetrahydropyrimidine derivatives have potential to design lead for anti-inflammatory activity.

背景,嘧啶类化合物是一类广泛的化合物,因其具有抗炎、COX抑制剂、抗癌、抗过敏、镇痛等多种生物活性而受到广泛关注。在详尽的文献回顾和PASS预测的基础上,我们发现取代的1,2,3,4四氢嘧啶衍生物具有良好的体外抗炎活性潜力。方法利用软件对合成化合物的毒性和药理活性进行研究。具有Pa(可能活性)的无毒化合物值大于0.3 &合成的不足0.5个。报道了以尿素(0.01 mmol)和双(甲基硫)甲基肠腈(0.01 mmol)为原料合成取代1,2,3,4-四氢嘧啶的新工艺。取代的1,2,3,4 -四氢嘧啶在第6位具有可取代的活性甲基硫基,该甲基硫基被选定的亲核试剂取代得到最终化合物。结果合成的化合物经IR、1H-NMR、MS和元素分析表征。以双氯芬酸为标准药,采用抑制蛋白变性法筛选化合物体外抗炎活性。结果显示,几乎所有被测试的化合物都显示出有效的体外抗炎活性。结论抗炎实验结果表明,有必要进一步研究化合物的抗炎作用机制。取代的1,2,3,4 -四氢嘧啶衍生物具有抗炎活性设计铅的潜力。
{"title":"Synthesis, characterization and in-vitro anti-inflammatory activity of some substituted 1,2,3,4 tetrahydropyrimidine derivatives","authors":"Anita S. Gondkar,&nbsp;Vinayak K. Deshmukh,&nbsp;Sanjay R. Chaudhari","doi":"10.1016/j.dit.2013.04.004","DOIUrl":"10.1016/j.dit.2013.04.004","url":null,"abstract":"<div><h3>Background &amp; aim</h3><p>Pyrimidines represent a broad class of compounds, which have received considerable attention due to their wide range of biological activities such as, anti-inflammatory, COX inhibitor, anticancer, antiallergic and analgesic. On the basis of exhaustive literature review and PASS predictions, it has been found that substituted 1,2,3,4 tetrahydropyrimidine derivatives have good potential to exhibit <em>in vitro</em> anti-inflammatory activity.</p></div><div><h3>Method</h3><p>The toxicity and pharmacological activities of synthesized compounds were studied with the help of softwares. The non-toxic compounds, which are having Pa (Probable activity), value more than 0.3 &amp; less than 0.5 were synthesized. A novel procedure for synthesis of substituted 1,2,3,4-tetrahydropyrimidine was reported by the reaction of urea (0.01 mmol) and bis(methylthio)methylenemalononitrile (0.01 mmol). Substituted 1, 2, 3, 4-tetrahydropyrimidine possess a replaceable active methylthio group at the 6th position, which was substituted with selected nucleophiles to get final compounds.</p></div><div><h3>Result</h3><p>All synthesized compounds were characterized by IR, <sup>1</sup>H-NMR, MS and elemental analysis. All compounds were screened for <em>in-vitro</em> anti-inflammatory activity by inhibition of protein denaturation method using diclofenac as a standard drug. The results revealed that almost all the tested compounds showed potent in-vitro anti-inflammatory activity.</p></div><div><h3>Conclusion</h3><p>The obtained results for anti-inflammatory prove the necessity for further investigation to clarify the features underlying the anti-inflammatory potential of tested compounds. Substituted 1, 2, 3, 4-tetrahydropyrimidine derivatives have potential to design lead for anti-inflammatory activity.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 175-181"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.04.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76566117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Comparative evaluation of commercially available homology modelling tools: A structural bioinformatics perspective 商业上可用的同源建模工具的比较评价:结构生物信息学的观点
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.04.003
Sween Dahiya , Anjum Gahlaut , Mahesh Kulharia

Background

Structure based drug design has revolutionised the way new drug molecules are being looked for. A very important technique in this process is homology modelling of protein structures. Although a number of protocols are proposed by a number of research groups, yet a comparative assessment is desired to identify the relative merits and demerits of these programs. Comparative assessment of various homology modelling tools was evaluated using prediction of structure of B-domain of factor V.

Methods

The methods employed, here, for comparative assessment were ESyPred3D, SWISS MODEL, PHYRE2 and YASARA. The criteria for selection of these tools were their popularity among users and level of automation. All these are completely automated and require only protein sequence or alignments as input. These tools were fast and the results were obtained within few hours.

Results

To evaluate the various models of the protein structures, we carried out exhaustive evaluation through “WHATif” and “QMEAN”. The parameters included the bond angle, bond length, coarse packing quality control, collision symmetry, omega angle, hand check dihedrals etc.

Conclusion

According to our study YASARA emerged as best performer.

基于结构的药物设计已经彻底改变了寻找新药物分子的方式。在这一过程中一个非常重要的技术是蛋白质结构的同源性建模。虽然许多研究小组提出了许多方案,但需要进行比较评估,以确定这些方案的相对优点和缺点。采用因子v的b域结构预测方法对不同的同源性建模工具进行比较评价。方法采用ESyPred3D、SWISS MODEL、PHYRE2和YASARA进行比较评价。选择这些工具的标准是它们在用户中的受欢迎程度和自动化程度。所有这些都是完全自动化的,只需要蛋白质序列或比对作为输入。这些工具速度快,在几个小时内就能得到结果。结果我们通过“WHATif”和“QMEAN”对各种蛋白质结构模型进行了详尽的评价。参数包括键合角、键合长度、粗填料质量控制、碰撞对称、欧米伽角、手检二面体等。结论根据我们的研究,YASARA表现最佳。
{"title":"Comparative evaluation of commercially available homology modelling tools: A structural bioinformatics perspective","authors":"Sween Dahiya ,&nbsp;Anjum Gahlaut ,&nbsp;Mahesh Kulharia","doi":"10.1016/j.dit.2013.04.003","DOIUrl":"10.1016/j.dit.2013.04.003","url":null,"abstract":"<div><h3>Background</h3><p>Structure based drug design has revolutionised the way new drug molecules are being looked for. A very important technique in this process is homology modelling of protein structures. Although a number of protocols are proposed by a number of research groups, yet a comparative assessment is desired to identify the relative merits and demerits of these programs. Comparative assessment of various homology modelling tools was evaluated using prediction of structure of B-domain of factor V.</p></div><div><h3>Methods</h3><p>The methods employed, here, for comparative assessment were ESyPred3D, SWISS MODEL, PHYRE2 and YASARA. The criteria for selection of these tools were their popularity among users and level of automation. All these are completely automated and require only protein sequence or alignments as input. These tools were fast and the results were obtained within few hours.</p></div><div><h3>Results</h3><p>To evaluate the various models of the protein structures, we carried out exhaustive evaluation through “WHATif” and “QMEAN”. The parameters included the bond angle, bond length, coarse packing quality control, collision symmetry, omega angle, hand check dihedrals etc.</p></div><div><h3>Conclusion</h3><p>According to our study YASARA emerged as best performer.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 207-211"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82785899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Design, characterization and evaluation of Eudragit microspheres containing glipizide 含格列吡嗪的乌龙茶微球的设计、表征和评价
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.06.009
Atrey S. Joshi , Chandrashekar C. Patil, Shivanand S. Shiralashetti, Navanath V. Kalyane

Objectives

The aim of the present investigation was to formulate and evaluate Eudragit microspheres for controlled release of glipizide.

Methods

The microspheres were produced by emulsion solvent evaporation method, using the Eudragit RS100, Eudragit RL100 and also by their combination. Further, the prepared microspheres were characterized for the micromeritic properties, drug loading as well as Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy. In vitro release study was performed in phosphate buffer (pH 7.4).

Results and discussion

The microspheres were free flowing in nature. The mean particle size ranged from 112 to 132 μm and the entrapment efficiencies ranged from 43.27 to 61.89%. The entrapment efficiency was found to be dependent on nature of polymer used for formulation. The FTIR confirmed stable character of glipizide in the drug-loaded microspheres. The DSC revealed the uniform dispersion of drug and polymer. Scanning electron microscopy revealed the surface morphology. The mechanism of drug release from the microsphere was found to be non-fickian type.

Conclusion

Eudragit microsphere containing glipizide was prepared successfully by using an emulsion solvent evaporation technique.

目的制备并评价用于格列吡嗪控释的乌龙木微球。方法采用乳化液溶剂蒸发法制备微球,以乌桕油RS100、乌桕油RL100为原料制备微球。进一步对所制备的微球进行了微观性质、载药量、傅里叶变换红外光谱(FTIR)和扫描电镜表征。在磷酸盐缓冲液(pH 7.4)中进行体外释放研究。结果与讨论微球在自然界中是自由流动的。平均粒径为112 ~ 132 μm,捕集效率为43.27% ~ 61.89%。发现包封效率取决于用于配方的聚合物的性质。FTIR证实了格列吡嗪在载药微球中的稳定性。DSC显示了药物和聚合物的均匀分布。扫描电镜显示了表面形貌。药物从微球释放的机制为非粘性型。结论采用乳状溶剂蒸发法制备了含格列吡嗪的乌龙珠微球。
{"title":"Design, characterization and evaluation of Eudragit microspheres containing glipizide","authors":"Atrey S. Joshi ,&nbsp;Chandrashekar C. Patil,&nbsp;Shivanand S. Shiralashetti,&nbsp;Navanath V. Kalyane","doi":"10.1016/j.dit.2013.06.009","DOIUrl":"10.1016/j.dit.2013.06.009","url":null,"abstract":"<div><h3>Objectives</h3><p>The aim of the present investigation was to formulate and evaluate Eudragit microspheres for controlled release of glipizide.</p></div><div><h3>Methods</h3><p>The microspheres were produced by emulsion solvent evaporation method, using the Eudragit RS100, Eudragit RL100 and also by their combination. Further, the prepared microspheres were characterized for the micromeritic properties, drug loading as well as Fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy. In vitro release study was performed in phosphate buffer (pH 7.4).</p></div><div><h3>Results and discussion</h3><p>The microspheres were free flowing in nature. The mean particle size ranged from 112 to 132 μm and the entrapment efficiencies ranged from 43.27 to 61.89%. The entrapment efficiency was found to be dependent on nature of polymer used for formulation. The FTIR confirmed stable character of glipizide in the drug-loaded microspheres. The DSC revealed the uniform dispersion of drug and polymer. Scanning electron microscopy revealed the surface morphology. The mechanism of drug release from the microsphere was found to be non-fickian type.</p></div><div><h3>Conclusion</h3><p>Eudragit microsphere containing glipizide was prepared successfully by using an emulsion solvent evaporation technique.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 229-234"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.06.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91281422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Imipenem resistance and biofilm production in Acinetobacter 不动杆菌对亚胺培南的耐药性和生物膜的产生
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.04.005
Anu Madanan Sunu Kumari, Abhisek Routray, Deepti Yadav, Radha Madhavan

Background

Acinetobacter spp. has emerged as a significant hospital pathogen because it is quickly becoming resistant to commonly used routine drugs and is able to survive on various biotic and abiotic surfaces. The main objective of this study is to isolate various clinical strains of Acinetobacter and to analyze its imipenem resistance pattern and biofilm formation.

Materials and methods

Acinetobacter strains were isolated from various clinical isolates. Resistance to imipenem was determined by both disk diffusion and minimum inhibitory concentration (MIC) methods. Biofilm production as a marker of virulence factor was also determined by microtiter plate method.

Results

65 strains of Acinetobacter isolated from various clinical samples. Resistance to imipenem was determined by performing minimum inhibitory concentration (MIC) which showed 46% resistance, compared with disk diffusion i.e. (32.3%). Among 65 strains, 7 were strong biofilm producers, 18 were moderate biofilm producers, 20 were weak biofilm producers and 20 were non biofilm producers. The association of biofilm production and imipenem resistance was found to be statistically significant.

Conclusion

Strains of Acinetobacter showing multi drug resistance and biofilm production remain as a great threat in hospital environment.

不动杆菌已经成为一种重要的医院病原体,因为它迅速对常用的常规药物产生耐药性,并且能够在各种生物和非生物表面生存。本研究的主要目的是分离各种临床不动杆菌菌株,并分析其亚胺培南耐药模式和生物膜形成情况。材料与方法从临床分离株中分离出动杆菌菌株。采用纸片扩散法和最小抑菌浓度法测定对亚胺培南的耐药性。用微滴板法测定了作为毒力因子标志的生物膜产量。结果从不同临床标本中分离出不动杆菌65株。最小抑菌浓度(MIC)测定对亚胺培南的耐药率为46%,而纸片扩散法(MIC)的耐药率为32.3%。65株菌株中,强生膜菌7株,中等生膜菌18株,弱生膜菌20株,无生膜菌20株。生物膜的产生与亚胺培南耐药的关系具有统计学意义。结论不动杆菌具有多重耐药和生物膜生成的特点,是医院环境的一大威胁。
{"title":"Imipenem resistance and biofilm production in Acinetobacter","authors":"Anu Madanan Sunu Kumari,&nbsp;Abhisek Routray,&nbsp;Deepti Yadav,&nbsp;Radha Madhavan","doi":"10.1016/j.dit.2013.04.005","DOIUrl":"10.1016/j.dit.2013.04.005","url":null,"abstract":"<div><h3>Background</h3><p><em>Acinetobacter spp</em>. has emerged as a significant hospital pathogen because it is quickly becoming resistant to commonly used routine drugs and is able to survive on various biotic and abiotic surfaces. The main objective of this study is to isolate various clinical strains of <em>Acinetobacter</em> and to analyze its imipenem resistance pattern and biofilm formation.</p></div><div><h3>Materials and methods</h3><p><em>Acinetobacter</em> strains were isolated from various clinical isolates. Resistance to imipenem was determined by both disk diffusion and minimum inhibitory concentration (MIC) methods. Biofilm production as a marker of virulence factor was also determined by microtiter plate method.</p></div><div><h3>Results</h3><p>65 strains of <em>Acinetobacter</em> isolated from various clinical samples. Resistance to imipenem was determined by performing minimum inhibitory concentration (MIC) which showed 46% resistance, compared with disk diffusion i.e. (32.3%). Among 65 strains, 7 were strong biofilm producers, 18 were moderate biofilm producers, 20 were weak biofilm producers and 20 were non biofilm producers. The association of biofilm production and imipenem resistance was found to be statistically significant.</p></div><div><h3>Conclusion</h3><p>Strains of <em>Acinetobacter</em> showing multi drug resistance and biofilm production remain as a great threat in hospital environment.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 256-258"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.04.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90386677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Virtual screening on potential neuraminidase inhibitors of influenza A virus H1N1 甲型H1N1流感病毒潜在神经氨酸酶抑制剂的虚拟筛选
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.06.005
Salam Pradeep Singh , Dhrubajyoti Gogoi , Rajib Lochan Bezbaruah , Manab Jyoti Bordoloi , Nabin Chandra Barua

Background

Influenza A virus H1N1 causes human influenza (flu) in 2009. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a small fraction of all seasonal influenza. Zanamivir which blocks the function of the viral neuraminidase protein of influenza A virus H1N1, thus preventing the virus from reproducing by budding from the host cell has been reported for having resistance against the virus. The neuraminidase enzyme is a glycoside hydrolase enzyme which is found on the surface. It enables the virus to be released from the host cell and cleave sialic acid groups from glycoproteins and is required for influenza virus replication. The World Health Organization declared the H1N1 influenza pandemic on August 10, 2010.

Methods

The present work focuses on the in silico virtual screening and molecular docking analysis for potential neuraminidase inhibitors using zanamivir like molecules retrieved from the ZINC database. The zanamivir like molecules were further inspected for PASS prediction and ADME-Toxicity analysis using in silico approaches.

Results

Molecular docking results suggest ZINC01696606, ZINC05069324 and ZINC02468939 have better binding affinity than zanamivir and better pharmacological parameters than zanamivir.

Conclusion

Zanamivir like molecules viz. ZINC01696606, ZINC05069324 and ZINC02468939 support experimental testingas zanamivir is reported for having resistance against neuraminidase enzyme and bioavailability problems.

背景甲型流感病毒H1N1在2009年引起人类流感(流感)。一些H1N1毒株在人类中流行,在所有流感样疾病和所有季节性流感中只占一小部分。扎那米韦阻断甲型流感病毒H1N1的病毒神经氨酸酶蛋白的功能,从而阻止病毒从宿主细胞出芽繁殖,据报道对该病毒具有耐药性。神经氨酸酶是一种存在于表面的糖苷水解酶。它使病毒能够从宿主细胞中释放出来,并从糖蛋白中切割唾液酸基团,这是流感病毒复制所必需的。世界卫生组织于2010年8月10日宣布H1N1流感大流行。方法利用从锌数据库中检索到的扎那米韦类分子,对潜在的神经氨酸酶抑制剂进行计算机虚拟筛选和分子对接分析。扎那米韦样分子进一步检测PASS预测和adme毒性分析使用计算机方法。结果分子对接结果表明,ZINC01696606、ZINC05069324和ZINC02468939的结合亲和力优于扎那米韦,药理参数优于扎那米韦。结论扎那米韦类分子(ZINC01696606、ZINC05069324和ZINC02468939)具有抗神经氨酸酶耐药和生物利用度问题,支持实验检测。
{"title":"Virtual screening on potential neuraminidase inhibitors of influenza A virus H1N1","authors":"Salam Pradeep Singh ,&nbsp;Dhrubajyoti Gogoi ,&nbsp;Rajib Lochan Bezbaruah ,&nbsp;Manab Jyoti Bordoloi ,&nbsp;Nabin Chandra Barua","doi":"10.1016/j.dit.2013.06.005","DOIUrl":"10.1016/j.dit.2013.06.005","url":null,"abstract":"<div><h3>Background</h3><p>Influenza A virus H1N1 causes human influenza (flu) in 2009. Some strains of H1N1 are endemic in humans and cause a small fraction of all influenza-like illness and a small fraction of all seasonal influenza. Zanamivir which blocks the function of the viral neuraminidase protein of influenza A virus H1N1, thus preventing the virus from reproducing by budding from the host cell has been reported for having resistance against the virus. The neuraminidase enzyme is a glycoside hydrolase enzyme which is found on the surface. It enables the virus to be released from the host cell and cleave sialic acid groups from glycoproteins and is required for influenza virus replication. The World Health Organization declared the H1N1 influenza pandemic on August 10, 2010.</p></div><div><h3>Methods</h3><p>The present work focuses on the in silico virtual screening and molecular docking analysis for potential neuraminidase inhibitors using zanamivir like molecules retrieved from the ZINC database. The zanamivir like molecules were further inspected for PASS prediction and ADME-Toxicity analysis using in silico approaches.</p></div><div><h3>Results</h3><p>Molecular docking results suggest ZINC01696606, ZINC05069324 and ZINC02468939 have better binding affinity than zanamivir and better pharmacological parameters than zanamivir.</p></div><div><h3>Conclusion</h3><p>Zanamivir like molecules viz. ZINC01696606, ZINC05069324 and ZINC02468939 support experimental testingas zanamivir is reported for having resistance against neuraminidase enzyme and bioavailability problems.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 241-245"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.06.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74326109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Glyceryl monostearate based nanoparticles of mefenamic acid: Fabrication and in vitro characterization 单硬脂酸甘油基甲氧胺酸纳米颗粒:制备和体外表征
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.06.011
Rabee Kumar , Mohd Yasir , Shubhini A. Saraf , Praveen K. Gaur , Yatendra Kumar , Alok Pratap Singh

Objective

The aim of present research work was to fabricate and evaluate the Mefenamic acid (MF) loaded Solid lipid nanoparticles (SLNs) using Glyceryl monostearate as lipid and tween 80 as surfactant.

Method

MF loaded SLNs were prepared by Solvent Emulsification diffusion technique. Various batches were prepared by hit and trial method varying drug to lipid ratio and surfactant concentration and evaluated for particle size & distribution, particle morphology, zeta potential, percent drug loading and percent drug entrapment efficiency.

Result

Among various lipids like Glyceryl monostearate, Stearic acid and Palmitic acid, GMS was selected for the fabrication of SLNs it was due to the highest solubility of MF in GMS as compared to other above mentioned lipids. Particle size, polydispersity index (PDI), zeta potential, percent drug loading and percent drug entrapment efficiency were found to be 109.7 nm, 0.34, −20.3 mV, 43.00 and 75.45 respectively. Morphologically the SLNs were found to be spherical with rough surfaces. The optimized formulation exhibited 93.28% cumulative drug release after 24 h, while the release mechanism was found to be Fickian diffusion type.

Conclusion

It is concluded that Solvent Emulsification diffusion technique is suitable for fabrication of MF loaded SLNs. All evaluating parameters of optimized SLNs were found to be in acceptable range.

目的以单硬脂酸甘油酯为脂质,吐温80为表面活性剂,制备载甲氧胺酸固体脂质纳米颗粒(SLNs),并对其性能进行评价。方法采用溶剂乳化扩散法制备负载mf的sln。不同药脂比和表面活性剂浓度制备了不同批次的样品,并对其粒径进行了评价;分布、颗粒形态、zeta电位、载药量百分比和载药量百分比。结果在单硬脂酸甘油酯、硬脂酸和棕榈酸等多种脂质中,由于MF在GMS中的溶解度高于其他脂质,因此选择GMS作为制备sln的原料。粒径为109.7 nm, PDI为0.34,zeta电位为- 20.3 mV,载药率为43.00,包封率为75.45。形貌上发现sln为球形,表面粗糙。优化后的制剂在24 h后的累积释药量为93.28%,释药机制为菲克扩散型。结论溶剂乳化扩散技术适用于制备负载MF的sln。优化后的sln的评价参数均在可接受范围内。
{"title":"Glyceryl monostearate based nanoparticles of mefenamic acid: Fabrication and in vitro characterization","authors":"Rabee Kumar ,&nbsp;Mohd Yasir ,&nbsp;Shubhini A. Saraf ,&nbsp;Praveen K. Gaur ,&nbsp;Yatendra Kumar ,&nbsp;Alok Pratap Singh","doi":"10.1016/j.dit.2013.06.011","DOIUrl":"10.1016/j.dit.2013.06.011","url":null,"abstract":"<div><h3>Objective</h3><p>The aim of present research work was to fabricate and evaluate the Mefenamic acid (MF) loaded Solid lipid nanoparticles (SLNs) using Glyceryl monostearate as lipid and tween 80 as surfactant.</p></div><div><h3>Method</h3><p>MF loaded SLNs were prepared by Solvent Emulsification diffusion technique. Various batches were prepared by hit and trial method varying drug to lipid ratio and surfactant concentration and evaluated for particle size &amp; distribution, particle morphology, zeta potential, percent drug loading and percent drug entrapment efficiency.</p></div><div><h3>Result</h3><p>Among various lipids like Glyceryl monostearate, Stearic acid and Palmitic acid, GMS was selected for the fabrication of SLNs it was due to the highest solubility of MF in GMS as compared to other above mentioned lipids. Particle size, polydispersity index (PDI), zeta potential, percent drug loading and percent drug entrapment efficiency were found to be 109.7 nm, 0.34, −20.3 mV, 43.00 and 75.45 respectively. Morphologically the SLNs were found to be spherical with rough surfaces. The optimized formulation exhibited 93.28% cumulative drug release after 24 h, while the release mechanism was found to be Fickian diffusion type.</p></div><div><h3>Conclusion</h3><p>It is concluded that Solvent Emulsification diffusion technique is suitable for fabrication of MF loaded SLNs. All evaluating parameters of optimized SLNs were found to be in acceptable range.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 246-250"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.06.011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86203743","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 22
Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique 反离子诱导聚集法制备甲磺酸沙奎那韦微颗粒:高渗透技术探讨
Pub Date : 2013-09-01 DOI: 10.1016/j.dit.2013.07.002
Harekrishna Roy , Chandan Kumar Brahma , Ravi Kumar , Sisir Nandi

Objective

The objective of present work is to formulate saquinavir mesylate loaded microparticle by counterion induced aggregation method, employing simultaneous cold temperature and hyperosmotic solution treatment as new and novel technique.

Method

Chitosan was chosen as polycation and smaller molecular electrolytes such as sodium citrate, sodium sulphate and sodium orthophosphate were chosen as polyanions. The resulted aggregated microparticles were subjected to surface morphology, size distribution, in-vitro release and drug excipient interaction study.

Results and discussion

Sodium citrate (SC) and sodium sulphate (SS) were able to form aggregates except sodium orthophosphate (SP), as chitosan forms complexes and depends on pH and pKa of medium. Prepared aggregates were subjected to cold hyperosmotic dextrose solution to provide more mechanical strength. The percentage of entrapped drug was more in SC based microparticle as compared to SS. The SS and SC microparticles had average particle size of 1400 μm and 1200 μm respectively. Also, the SEM study revealed more rough and ridges on surface of SC particle as compared to SS. The higher correlation coefficient (r2) was found with Higuchi's equation for all formulations and formulation SS2 had greater r2 value of 0.986 compared to all and obeyed fickian diffusion. There was no such major interaction were found during FTIR and DSC study. In addition, stability study was performed and data showed no significant change in assay value for SS2.

Conclusion

The microparticles prepared by above mentioned method had sufficient mechanical strength and were able to released drug for a period of 30 h. Furthermore in-vivo study and pharmacokinetic study have to carry out.

目的采用反离子诱导聚集法制备甲磺酸沙奎那韦微球,同时采用低温和高渗溶液处理作为新技术。方法以壳聚糖为聚阳离子,柠檬酸钠、硫酸钠、正磷酸钠等小分子电解质为聚阴离子。对聚集体微颗粒进行了表面形貌、大小分布、体外释放和药物赋形剂相互作用研究。结果与讨论除正磷酸钠(SP)外,柠檬酸钠(SC)和硫酸钠(SS)均能形成聚集体,因为壳聚糖能形成络合物,并取决于介质的pH和pKa。制备的聚集体经受冷高渗葡萄糖溶液,以提供更多的机械强度。SC基微粒子的包封率高于SS基微粒子,SC基微粒子的平均粒径分别为1400 μm和1200 μm。同时,SEM研究发现SC颗粒表面比SS更粗糙、有更多的脊状结构。所有配方与Higuchi方程的相关系数(r2)均较高,其中SS2的r2值为0.986,符合菲克式扩散。在FTIR和DSC研究中没有发现这种主要的相互作用。此外,进行了稳定性研究,数据显示SS2的测定值没有显著变化。结论该方法制备的微颗粒具有足够的机械强度,并能在30 h内释放药物,还需进一步进行体内研究和药代动力学研究。
{"title":"Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique","authors":"Harekrishna Roy ,&nbsp;Chandan Kumar Brahma ,&nbsp;Ravi Kumar ,&nbsp;Sisir Nandi","doi":"10.1016/j.dit.2013.07.002","DOIUrl":"10.1016/j.dit.2013.07.002","url":null,"abstract":"<div><h3>Objective</h3><p>The objective of present work is to formulate saquinavir mesylate loaded microparticle by counterion induced aggregation method, employing simultaneous cold temperature and hyperosmotic solution treatment as new and novel technique.</p></div><div><h3>Method</h3><p>Chitosan was chosen as polycation and smaller molecular electrolytes such as sodium citrate, sodium sulphate and sodium orthophosphate were chosen as polyanions. The resulted aggregated microparticles were subjected to surface morphology, size distribution, in-vitro release and drug excipient interaction study.</p></div><div><h3>Results and discussion</h3><p>Sodium citrate (SC) and sodium sulphate (SS) were able to form aggregates except sodium orthophosphate (SP), as chitosan forms complexes and depends on pH and pKa of medium. Prepared aggregates were subjected to cold hyperosmotic dextrose solution to provide more mechanical strength. The percentage of entrapped drug was more in SC based microparticle as compared to SS. The SS and SC microparticles had average particle size of 1400 μm and 1200 μm respectively. Also, the SEM study revealed more rough and ridges on surface of SC particle as compared to SS. The higher correlation coefficient (<em>r</em><sup>2</sup>) was found with Higuchi's equation for all formulations and formulation SS2 had greater <em>r</em><sup>2</sup> value of 0.986 compared to all and obeyed fickian diffusion. There was no such major interaction were found during FTIR and DSC study. In addition, stability study was performed and data showed no significant change in assay value for SS2.</p></div><div><h3>Conclusion</h3><p>The microparticles prepared by above mentioned method had sufficient mechanical strength and were able to released drug for a period of 30 h. Furthermore in-vivo study and pharmacokinetic study have to carry out.</p></div>","PeriodicalId":11284,"journal":{"name":"Drug Invention Today","volume":"5 3","pages":"Pages 259-266"},"PeriodicalIF":0.0,"publicationDate":"2013-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.dit.2013.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91329401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
期刊
Drug Invention Today
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1